Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Haak

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
The Lancet Regional Health. Europe|November 13, 2023
Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trialNorbert Hermanns, Dominic Ehrmann, Katharina Finke-Groene, et al.
Diabetes, Obesity & Metabolism|April 28, 2017
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetesDavid R Owens, Geremia B Bolli, Bernard Charbonnel, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 16, 2024
Therapy for Type 1 DiabetesThomas Haak, Stefan Gölz, Andreas Fritsche, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 21, 2019
Therapy of Type 1 DiabetesThomas Haak, Stefan Gölz, Andreas Fritsche, et al.
Diabetes Research and Clinical Practice|February 9, 2020
The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectivesAntonio Ceriello, Harold W deValk, Bruno Guerci, et al.
Psychiatry Research|January 24, 2021
Non-suicidal self-injury in adolescents and young adults with type 1 diabetes: clinical characteristics from a German diabetes-patient registry (DPV)Alexander Eckert, Matthias Domhardt, Christina Reinauer, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 4, 2022
Therapy of Type 1 DiabetesThomas Haak, Stefan Gölz, Andreas Fritsche, et al.
Diabetes Care|January 22, 2015
The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trialNorbert Hermanns, Andreas Schmitt, Annika Gahr, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2006
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathyCarsten A Böger, Mike Stubanus, Thomas Haak, et al.
Diabetes, Obesity & Metabolism|July 10, 2024
Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in GermanyMarie Auzanneau, Jochen Seufert, Stefan Zimny, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
The Lancet Regional Health. Europe|November 13, 2023
Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trialNorbert Hermanns, Dominic Ehrmann, Katharina Finke-Groene, et al.
Diabetes, Obesity & Metabolism|April 28, 2017
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetesDavid R Owens, Geremia B Bolli, Bernard Charbonnel, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 16, 2024
Therapy for Type 1 DiabetesThomas Haak, Stefan Gölz, Andreas Fritsche, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 21, 2019
Therapy of Type 1 DiabetesThomas Haak, Stefan Gölz, Andreas Fritsche, et al.
Diabetes Research and Clinical Practice|February 9, 2020
The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectivesAntonio Ceriello, Harold W deValk, Bruno Guerci, et al.
Psychiatry Research|January 24, 2021
Non-suicidal self-injury in adolescents and young adults with type 1 diabetes: clinical characteristics from a German diabetes-patient registry (DPV)Alexander Eckert, Matthias Domhardt, Christina Reinauer, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 4, 2022
Therapy of Type 1 DiabetesThomas Haak, Stefan Gölz, Andreas Fritsche, et al.
Diabetes Care|January 22, 2015
The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trialNorbert Hermanns, Andreas Schmitt, Annika Gahr, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 29, 2006
Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathyCarsten A Böger, Mike Stubanus, Thomas Haak, et al.
Diabetes, Obesity & Metabolism|July 10, 2024
Regional socioeconomic deprivation associated with the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes in GermanyMarie Auzanneau, Jochen Seufert, Stefan Zimny, et al.
Pageof 10